DossierENTITY

gene-editing biotechnology

Coverage of gene-editing biotechnology in the Nexus archive.

Earliest in view: Jul 16 · 03:03 UTCMost recent: Jul 16 · 03:03 UTC

Co-mentioned in this coverage

Recent coverage

BUSINESSJul 16 · 03:03 UTCSCMP CHINA
Mainland China funds increase stakes in Hong Kong biotech amid surge of licensing deals
Mainland China institutional fund managers have increased investments in Hong Kong-listed biotech stocks due to attractive valuations and rising cross-border licensing deals. E Fund Management acquired a 7% stake in Biocytogen Pharmaceuticals by purchasing additional shares.